Ampeak Energy Welcomes New Strategic Shareholder in Positive Step Forward, says Longspur Research 23 February 2026
Drax Group’s Second Tolling Agreement Builds Momentum In Battery Storage, says Longspur Research 20 February 2026
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Diverse Income Trust Plc offers shareholders 100% cash exit or rollover option (LON: DIVI) 25 February 2026
Worldwide Healthcare Trust PLC (WWH.L) Stock Analysis: A Lucrative Opportunity with a 408% Revenue Surge 27 February 2026
Workspace Group PLC (WKP.L) Stock Analysis: Navigating the Challenges with a Promising Dividend Yield 27 February 2026
ZIGUP PLC (ZIG.L) Stock Analysis: Potential Upside and Strong Dividend Yield Draw Investor Attention 27 February 2026
Victrex PLC (VCT.L) Investor Outlook: Analyzing a Robust 8.52% Dividend Yield Amidst a Challenging Market Environment 27 February 2026
Volution Group PLC (FAN.L) Stock Analysis: Unpacking the 32.10% Revenue Growth and 7.76% Upside Potential 27 February 2026
Ampeak Energy Welcomes New Strategic Shareholder in Positive Step Forward, says Longspur Research 23 February 2026
Drax Group’s Second Tolling Agreement Builds Momentum In Battery Storage, says Longspur Research 20 February 2026
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Diverse Income Trust Plc offers shareholders 100% cash exit or rollover option (LON: DIVI) 25 February 2026
Worldwide Healthcare Trust PLC (WWH.L) Stock Analysis: A Lucrative Opportunity with a 408% Revenue Surge 27 February 2026
Workspace Group PLC (WKP.L) Stock Analysis: Navigating the Challenges with a Promising Dividend Yield 27 February 2026
ZIGUP PLC (ZIG.L) Stock Analysis: Potential Upside and Strong Dividend Yield Draw Investor Attention 27 February 2026
Victrex PLC (VCT.L) Investor Outlook: Analyzing a Robust 8.52% Dividend Yield Amidst a Challenging Market Environment 27 February 2026
Volution Group PLC (FAN.L) Stock Analysis: Unpacking the 32.10% Revenue Growth and 7.76% Upside Potential 27 February 2026
Talkspace, Inc. (TALK) Investor Outlook: A Healthcare Disruptor with 34.92% Potential Upside 19 December 2025
Keros Therapeutics, Inc. (KROS) Investor Outlook: A 16% Upside Potential with Robust Revenue Growth 19 December 2025
Replimune Group, Inc. (REPL) Stock Analysis: Unveiling the 29.74% Potential Upside in Biotech 19 December 2025
Cogent Biosciences, Inc. (COGT) Stock Analysis: A Biotech Gem with 29% Upside Potential 19 December 2025
Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Navigating a 55.66% Potential Upside in Biotech 19 December 2025
KalVista Pharmaceuticals, Inc. (KALV): Analyst Consensus Reveals Over 100% Potential Upside 19 December 2025
Bicycle Therapeutics plc (BCYC) Stock Analysis: Exploring a 217.58% Potential Upside 19 December 2025
Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Exploring a 239% Upside Potential in Innovative Cancer Therapies 19 December 2025
Eton Pharmaceuticals (ETON) Investor Outlook: Exploring an 87% Potential Upside in the Rare Disease Market 19 December 2025
Bicara Therapeutics Inc. (BCAX) Stock Analysis: Unpacking the 84.65% Potential Upside for Investors 19 December 2025
GH Research PLC (GHRS) Stock Analysis: Exploring a 138.80% Upside in the Biotech Sector 19 December 2025
Xencor, Inc. (XNCR) Investor Outlook: An 80% Upside Potential in the Biotech Frontier 19 December 2025
Pharvaris N.V. (PHVS) Stock Analysis: Potential Upside of Over 90% Beckons Investors 19 December 2025
Sionna Therapeutics, Inc. (SION) Stock Analysis: Strong Buy Ratings Amidst Promising Cystic Fibrosis Pipeline 19 December 2025
Embecta Corp. (EMBC) Stock Analysis: Exploring a 42% Potential Upside in the Healthcare Sector 19 December 2025
SI-BONE, Inc. (SIBN) Stock Analysis: A Robust 27.85% Potential Upside Beckons Investors 19 December 2025
Arcus Biosciences, Inc. (RCUS) Stock Analysis: Unveiling a 45.98% Upside Potential Amidst Clinical Innovations 19 December 2025
RxSight, Inc. (RXST) Stock Analysis: Navigating a -16.06% Potential Downside with Innovative Technology 19 December 2025
Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Strong Revenue Growth and Promising Analyst Ratings 19 December 2025
XP Factory: Escape Hunt Delivers Record Margins as Boom Battle Bar Fuels Top-Line Growth (Video) 10 December 2025
Elemental Royalty Corporation: Unlocking long-term value through high-impact royalties (Video) 10 December 2025
NB Private Equity Partners: Buybacks, Exits and a Quiet Rebound Investors Are Missing (Video) 24 November 2025
Verge Technologies: Why SentientDB Is Mission-Critical in a Multi-Cloud World (Video) 24 November 2025
Cavendish Plc Market Resilience, Deep Value, and a 7.5% Yield That’s Hard to Ignore (Video) 24 November 2025
Unilever Delivers 3.5% Underlying Sales Growth in 2025 as Portfolio Reshaping Advances 12 February 2026
Likewise Group Tony Brewer: Capturing beyond 10% of £2 billion flooring market (Video) 10 November 2023
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Diverse Income Trust Plc offers shareholders 100% cash exit or rollover option (LON: DIVI) 25 February 2026
Ampeak Energy Welcomes New Strategic Shareholder in Positive Step Forward, says Longspur Research 23 February 2026
Drax Group’s Second Tolling Agreement Builds Momentum In Battery Storage, says Longspur Research 20 February 2026
Worldwide Healthcare Trust PLC (WWH.L) Stock Analysis: A Lucrative Opportunity with a 408% Revenue Surge 27 February 2026
Workspace Group PLC (WKP.L) Stock Analysis: Navigating the Challenges with a Promising Dividend Yield 27 February 2026
ZIGUP PLC (ZIG.L) Stock Analysis: Potential Upside and Strong Dividend Yield Draw Investor Attention 27 February 2026
Victrex PLC (VCT.L) Investor Outlook: Analyzing a Robust 8.52% Dividend Yield Amidst a Challenging Market Environment 27 February 2026
Volution Group PLC (FAN.L) Stock Analysis: Unpacking the 32.10% Revenue Growth and 7.76% Upside Potential 27 February 2026
